Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
antiprotozoal drug |
| gptkbp:approvalYear |
2004
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01XD02
|
| gptkbp:CASNumber |
19387-91-8
|
| gptkbp:chemicalFormula |
C8H13N3O4S
|
| gptkbp:contraindication |
first trimester of pregnancy
hypersensitivity to nitroimidazoles |
| gptkbp:discoveredBy |
gptkb:Pfizer
|
| gptkbp:drugClass |
nitroimidazole
|
| gptkbp:eliminationHalfLife |
12-14 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tinidazole
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
disrupts DNA synthesis in microorganisms
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
247.28 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:Metronidazole
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
fatigue headache metallic taste |
| gptkbp:synonym |
Fasigyn
Tindamax |
| gptkbp:usedFor |
treatment of giardiasis
treatment of amoebiasis treatment of bacterial vaginosis treatment of trichomoniasis |
| gptkbp:bfsParent |
gptkb:Trichomoniasis
|
| gptkbp:bfsLayer |
5
|